Highly recommend the powerful talk by our patient panelist Ms. Cheryl Bradford discuss her experience with #sarcoidosis during our symposium on healthcare disparities at #ats2021! LIVE NOW please join us @StopSarcoidosis@rtg03@EnnisjamesM @mwsharp5 @elizabetharkema
@GinnyMarmolejos @TempleLung@accpchest Thanks for listening one of the super early session @GinnyMarmolejos and others who joined! It was a pleasure to speak besides the great gurus in the field of sarcoidosis! #CHEST2020
This is an unprecedented stance taken by the @NEJM editors. I applaud their courage in writing this editorial.
Dying in a Leadership Vacuum | NEJM https://t.co/eECrYxz06U
https://t.co/XmYy4pSKBg our experience: we didn’t notice any impact of cytokines storm treatment on VTE. And half of the VTE happened within 48-72 hours of presentations and others after 6-7 days @TempleLung@TempleHealth@accpchest@PERTConsortium@ATSMedEd@ATS_PC
Huge thanks to the hard-working #AJRCCM Early Career Group’s Junior Editors-In-Training 2019-2020. Delighted to introduce our newly-appointed & highly talented 2020-2021 team - Welcome! These are the editors of the future. @atscommunity@ATSBlueEditor https://t.co/zyBCTjwgUV
A patient who was recently diagnosed with Sarcoidosis was referred to the Temple Lung Center, where Dr. @rtg03 was able to eliminate medication completely. @6abc@TempleHealth https://t.co/P2svIbcuwB
Steroids or no steroids! We all have seen both sides but need solid evidence which might not be the case soon. Need to treat patients in the interim....
possible role for low-dose steroid in COVID? Perhaps timed with the early inflammatory phase (e.g. ~5-10d after illness onset, when hypoxemia is worsening). Available evidence from SARS & COVID-19 suggests possible benefit - but *not* definitive.
(blog: https://t.co/AV1uuEW2Yz)